Table 1.
CNS disease | Responder cells | Mediators | ECM component |
---|---|---|---|
Acute damage | Astrocytes, microglia, leukocytes, meningeal cells, fibroblasts, pericytes | Thrombin, MMP-9, ATP, PDGFRβ, TGFβ | Fibronectin, laminin, collagen, CSPGs, tenascin, HSPGs |
ALS | Astrocytes, microglia, leukocytes, oligodendrocytes, meningeal cells, fibroblasts, pericytes | IL-6, CXCL1, CXCL10, CXCL12, TNFα, TGFβ, NGF, INFγ, PGD2, ADAMTS-4, CTGF, S100A4, MMP-9 | Fibronectin, collagen IV, CSPGs, Sema3A, fibrin, vimentin, thrombin |
MS | Astrocytes, microglia, leukocytes, endothelial cells, meningeal cells, fibroblasts, pericytes, oligodendrocytes | PDGFRβ, TGFβ, myelin | Collagen, fibronectin, biglycan, decorin, CSPGs |
AD | Astrocytes, microglia, leukocytes, smooth muscle cells, fibroblasts, pericytes | PDGFRβ, TGFβ | GAGs, HSPGs |
The table summarizes the main cellular components, mediators and ECM molecules involved in ALS, MS, and AD as well as in acute CNS damage. For a more extensive review of the many specific molecules that regulate or influence CNS cellular responses to acute conditions see (3, 4). CTGF, connective tissue growth factor; INFγ, interferon γ; MMP-9, matrix metalloprotease-9; NGF, nerve growth factor; PGD2, prostaglandin D2; TNFα, tumor necrosis factor α.